Nav: Home

World's largest transfusion study in cardiac surgery changes transfusion practices

August 27, 2018

TORONTO, August 27, 2018 - Lower thresholds for blood transfusions for cardiac surgery patients compared to traditional thresholds provide positive patient outcomes and safety at six months after surgery, according to the world's largest research study on this topic.

The research found that in addition to providing good patient outcomes six months after hospital discharge, the lower threshold - known as 'restrictive transfusion therapy' - reduces the amount of blood transfused and money spent on blood per procedure. The higher, traditional threshold is called 'liberal transfusion therapy.'

Physicians who practice the liberal transfusion approach give blood transfusions early in the surgery to prevent patients' hemoglobin level from falling. Hemoglobin is the protein that allows red blood cells to deliver oxygen to body tissues. Physicians who practice a restrictive approach wait longer to see if the hemoglobin level remains stable or if the patient has further bleeding.

These findings were presented on Sunday at the European Society of Cardiology Annual Congress in Munich, Germany by Dr. David Mazer, principal investigator on the study, anesthesiologist at St. Michael's Hospital, associate scientist in its Keenan Research Centre for Biomedical Science, and Professor of Anesthesia and Physiology at the University of Toronto, with simultaneous publication in the New England Journal of Medicine.

"Our research question was, at what point does the risk of anemia, or the risk of a lower hemoglobin, outweigh the risk of transfusion?" Dr. Mazer said. "We wanted to know whether it is safe to let your hemoglobin go to a lower level before you transfuse. The answer is yes. It'll save blood, make blood more available, reduce costs of transfusion and result in similar or better outcomes."

This work builds on Dr. Mazer's research published less than a year ago in the New England Journal of Medicine, which analyzed immediate postoperative patient outcomes. The randomized trial involved more than 5,200 patients at 74 sites in 19 countries and every continent in the world except Antarctica. At the six-month mark, data was available for 96 per cent of the patients.

Dr. Mazer, who co-led this study with Dr. Nadine Shehata, a hematologist at the Sinai Health System, and the research team found no clinical or statistical difference in four patient outcomes (death, heart attack, stroke and new kidney failure), whether the patients had contemporary restrictive therapy or traditional liberal practices. In fact, use of the restrictive transfusion protocol during and after heart surgery may actually reduce the incidence of complications in older patients, including heart attack, stroke, kidney failure and death.

"This research has already started to change transfusion practice around the world," said Dr. Mazer. "With this data at six months, we've proven the longer term safety of restrictive therapy. This approach has already been adopted into guidelines and will likely become the standard of care worldwide."

The large size of this study provides Dr. Mazer and his team additional opportunity to answer several other important questions related to transfusion and cardiac surgery.
-end-
This study received funding from the Canadian Institutes of Heart Research, Canadian Blood Services, the National Health and Medical Research Council in Australia and the Health Research Council of New Zealand.

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 29 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

St. Michael's Hospital with Providence Healthcare and St. Joseph's Health Centre now operate under one corporate entity as of August 1, 2017. United, the three organizations serve patients, residents and clients across the full spectrum of care, spanning primary care, secondary community care, tertiary and quaternary care services to post-acute through rehabilitation, palliative care and long-term care, while investing in world-class research and education.

Media contact

For more information, please contact: Ana Gajic
Senior Communications Advisor, Research
St. Michael's Hospital
Phone: 416-864-5960 or 416 458 0629
Gajica@smh.ca

St. Michael's Hospital

Related Heart Attack Articles:

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.
New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.
Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.
A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.
Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.
Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.
Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.
How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.
Heart attack patients taken directly to heart centers have better long-term survival
Heart attack patients taken directly to heart centers for lifesaving treatment have better long-term survival than those transferred from another hospital, reports a large observational study presented today at Acute Cardiovascular Care 2019, a European Society of Cardiology congress.
Among heart attack survivors, drug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.
More Heart Attack News and Heart Attack Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.